For Investors
85% failure prediction accuracy. We catch what others miss—before you write the check.
Most due diligence misses critical signals because evaluators lack either clinical context or engineering depth—rarely both.
What We Catch That Others Miss:
Our Services
Complete 18-category Vantage Score assessment with executive summary and recommendation. 2-3 week delivery.
Focused assessment of clinical validation, regulatory pathway, and physician adoption potential.
Focused assessment of IP position, manufacturing scalability, and supply chain risk.
Ongoing advisory for firms with multiple medical device investments. Priority access and volume pricing.
Structured expert calls with our MD or BME on specific questions. Quick-turn targeted insights.
Quick-turn assessment of critical risk areas. Identify deal-breakers in 3-5 days.
Data Security
Choose the security level that matches your engagement.
Secure cloud infrastructure with encryption at rest and in transit.
Additional controls for sensitive deals and competitive situations.
Complete isolation with local-only processing for maximum security.
Process
Define criteria aligned with your investment thesis.
Dr. Ravinutala evaluates clinical utility and adoption.
Aswini analyzes design, manufacturing, and IP.
Unified Vantage Score with recommendation.
Schedule a consultation to discuss your portfolio needs.
Schedule a Call